Segunda línea de tratamiento de pacientes con NSCLC PD-L1 positivo: - page 9

KEYNOTE-001: long-term OS by
PD-L1 expression
Analysis data cut-off: September 18, 2015.
Patients with unknown PD-L1 TPS were excluded.
CI: confidence interval; OS: overall survival; mo: months; PD-L1: programmed cell death ligand 1; TPS: tumour proportion
score; NR: not reached.
Adapted from Hui R
et al
. Presented at ASCO 2016. Poster 9026.
Median follow-up: 23.1m
1,2,3,4,5,6,7,8 10,11,12,13,14,15,16,17,18,19,...33
Powered by FlippingBook